BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37254528)

  • 1. Recent Advances in Drug Discovery for Parasitic Diseases.
    de Moraes J
    Curr Top Med Chem; 2023; 23(9):711-712. PubMed ID: 37254528
    [No Abstract]   [Full Text] [Related]  

  • 2. Expanding Bromodomain Targeting into Neglected Parasitic Diseases.
    Tallant C; Bamborough P; Chung CW; Gamo FJ; Kirkpatrick R; Larminie C; Martín J; Prinjha R; Rioja I; Simola DF; Gabarró R; Calderón F
    ACS Infect Dis; 2021 Nov; 7(11):2953-2958. PubMed ID: 34612618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug discovery for parasitic diseases: powered by technology, enabled by pharmacology, informed by clinical science.
    Rao SPS; Manjunatha UH; Mikolajczak S; Ashigbie PG; Diagana TT
    Trends Parasitol; 2023 Apr; 39(4):260-271. PubMed ID: 36803572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elimination and eradication of neglected tropical diseases with mass drug administrations: a survey of experts.
    Keenan JD; Hotez PJ; Amza A; Stoller NE; Gaynor BD; Porco TC; Lietman TM
    PLoS Negl Trop Dis; 2013; 7(12):e2562. PubMed ID: 24340111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated dataset of screening hits against multiple neglected disease pathogens.
    Nwaka S; Besson D; Ramirez B; Maes L; Matheeussen A; Bickle Q; Mansour NR; Yousif F; Townson S; Gokool S; Cho-Ngwa F; Samje M; Misra-Bhattacharya S; Murthy PK; Fakorede F; Paris JM; Yeates C; Ridley R; Van Voorhis WC; Geary T
    PLoS Negl Trop Dis; 2011 Dec; 5(12):e1412. PubMed ID: 22247786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Price hikes could affect treatment for NTDs in the USA.
    Nelson R
    Lancet Infect Dis; 2018 Feb; 18(2):150-151. PubMed ID: 29412967
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiparasitic therapy in children.
    Moon TD; Oberhelman RA
    Pediatr Clin North Am; 2005 Jun; 52(3):917-48, viii. PubMed ID: 15925668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug discovery for infectious agents causing neglected diseases.
    Silber AM; Pereira CA; Wrenger C
    Curr Med Chem; 2014; 21(15):1667. PubMed ID: 24304273
    [No Abstract]   [Full Text] [Related]  

  • 9. Ethical considerations in an era of mass drug administration.
    Wharam B; Lazarou L
    Parasit Vectors; 2013 Aug; 6():234. PubMed ID: 23937995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual Inhibition of Parasitic Targets: A Valuable Strategy to Treat Malaria and Neglected Tropical Diseases.
    Previti S; Di Chio C; Ettari R; Zappalà M
    Curr Med Chem; 2022; 29(17):2952-2978. PubMed ID: 34375176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transition-state-guided drug design for treatment of parasitic neglected tropical diseases.
    Murkin AS; Moynihan MM
    Curr Med Chem; 2014; 21(15):1781-93. PubMed ID: 24083604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiparasitic therapy.
    Kappagoda S; Singh U; Blackburn BG
    Mayo Clin Proc; 2011 Jun; 86(6):561-83. PubMed ID: 21628620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innovative partnerships for drug discovery against neglected diseases.
    Jakobsen PH; Wang MW; Nwaka S
    PLoS Negl Trop Dis; 2011 Sep; 5(9):e1221. PubMed ID: 21980540
    [No Abstract]   [Full Text] [Related]  

  • 14. Curcuma as a parasiticidal agent: a review.
    Haddad M; Sauvain M; Deharo E
    Planta Med; 2011 Apr; 77(6):672-8. PubMed ID: 21104602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic and Target-Site Pharmacokinetics of Antiparasitic Agents.
    Al Jalali V; Zeitlinger M
    Clin Pharmacokinet; 2020 Jul; 59(7):827-847. PubMed ID: 32100246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of cysteine protease inhibitors as chemotherapy for parasitic diseases: insights on safety, target validation, and mechanism of action.
    McKerrow JH
    Int J Parasitol; 1999 Jun; 29(6):833-7. PubMed ID: 10480720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Parasite-induced hypereosinophilia].
    Bourée P
    Presse Med; 2006 Jan; 35(1 Pt 2):153-66. PubMed ID: 16462680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrocyclic lactones in antiparasitic therapy. Editorial.
    González-Canga A
    Curr Pharm Biotechnol; 2012 May; 13(6):851-2. PubMed ID: 22587602
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of diseases caused by parasites].
    Pérez-Molina JA; Díaz-Menéndez M; Pérez-Ayala A; Ferrere F; Monje B; Norman F; López-Vélez R
    Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):44-59. PubMed ID: 20031280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infectious diseases. Tackling neglected diseases could offer more bang for the buck.
    Vogel G
    Science; 2006 Feb; 311(5761):592-3. PubMed ID: 16456044
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.